CIBC Asset Management
AGL icon

CIBC Asset Management’s Agilon Health AGL Stock Holding History

CIBC Asset Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-516
Closed -$8.89K – 1374
2025
Q4 		$8.89K Hold
516
– – ﹤0.01% 1366
2025
Q3 		$13.3K Hold
516
– – ﹤0.01% 1239
2025
Q2 		$29.7K Hold
516
– – ﹤0.01% 1209
2025
Q1 		$55.9K Buy
516
+12
+2% +$1.04K ﹤0.01% 1161
2024
Q4 		$23.9K Buy
504
+13
+3% +$786 ﹤0.01% 1216
2024
Q3 		$48.3K Buy
491
+14
+3% +$1.81K ﹤0.01% 1203
2024
Q2 		$78K Buy
+477
New +$68K ﹤0.01% 1110
2023
Q1 		– Sell
-435
Closed -$176K – 1070
2022
Q4 		$176K Sell
435
-193
-31% -$90.5K ﹤0.01% 956
2022
Q3 		$368K Hold
628
– – ﹤0.01% 825
2022
Q2 		$343K Sell
628
-41
-6% -$20.7K ﹤0.01% 829
2022
Q1 		$424K Buy
669
+1
+0.1% +$515 ﹤0.01% 887
2021
Q4 		$451K Buy
668
+42
+7% +$25.6K ﹤0.01% 871
2021
Q3 		$410K Buy
+626
New +$535K ﹤0.01% 875

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

CIBC Asset Management's AGL Position: Q1 2026 in Review

CIBC Asset Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 516 shares — an estimated $8.89K sold.

CIBC Asset Management first reported a position in AGL in Q3 2021 and held it in 13 quarters. The position peaked at $451K in Q4 2021. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • CIBC Asset Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • CIBC Asset Management sold 516 Agilon Health shares in Q1 2026, an estimated $8.89K.
  • CIBC Asset Management first reported a position in Agilon Health in Q3 2021 and held it in 13 quarters.
  • CIBC Asset Management's Agilon Health position peaked at $451K in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.